Audit & Compliance
What Is GxP Compliance?
GxP is the umbrella term for all "Good Practice" quality guidelines and regulations applied across the pharmaceutical, biotechnology, and medical device lifecycle. In Canada, GxP compliance is enforced by Health Canada and aligns with international frameworks from the FDA, EMA, ICH, and OECD.
Organizations that develop, manufacture, test, distribute, or market regulated health products in Canada must demonstrate continuous compliance with the applicable GxP standards. Failure to meet these standards can result in Health Canada Notices of Non-Compliance, import alerts, product recalls, or regulatory sanctions.
The GxP framework ensures that:
- Products are consistently manufactured and controlled to quality standards
- Clinical trial data is scientifically credible and ethically generated
- Laboratory data is reliable, traceable, and reproducible
- Distribution maintains product integrity from manufacturer to patient
- Pharmacovigilance systems detect and report safety signals post-market
The GxP Family of Standards
Each GxP standard governs a specific phase or function within the product lifecycle
| Standard | Full Name | Scope | Canadian Regulation |
| GMP | Good Manufacturing Practice | Drug manufacturing, packaging, testing, and release | Food and Drug Regulations, Division 2 (C.02.004–C.02.029) |
| GCP | Good Clinical Practice | Clinical trials involving human subjects | Food and Drug Regulations, Division 5; ICH E6(R3) |
| GLP | Good Laboratory Practice | Non-clinical laboratory studies for regulatory submission | OECD GLP Principles; Health Canada Guidance Documents |
